Medical News

RSS

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.

From Baxter International Inc. 25 Jun 2012

High suicide rates in specific regions or ethnic groups may be masked by falls in national rates for young men

In the second Series paper, Suicide in young men, a group of researchers led by Dr Alexandra Pitman of UCL (University College London) Mental Health Sciences Unit, UK, examine another under-investigated area of suicide research. After reviewing research published over the last decade, they found strikingly few studies distinguishing the factors which identify those young men (aged 19 – 30) at greatest risk of suicide.

25 Jun 2012

First Edition: June 25, 2012

Today's headlines are focused on analysis and speculation surrounding the Supreme Court's health law ruling, which could come as early as today.

25 Jun 2012

FDA approves Actavis Mixed Amphetamine Salts ER Capsules

Actavis Group, an international generic pharmaceuticals company, today announced that it has received approval from the US Food & Drug Administration to market Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Capsules CII, (hereafter referred to as Mixed Amphetamine Salts ER Capsules), in all available strengths: 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg.

25 Jun 2012

Self-harm and suicide in young people: the role of new media

In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford’s Centre for Suicide Research, and Professor Rory O’Connor of University of Stirling’s Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.

25 Jun 2012

Staff at Sheffield Teaching Hospitals shortlisted for more awards than any other trust in the country

Teams of staff at Sheffield Teaching Hospitals have been recognised for their hard work by gaining more shortlisted entries in two high profile national award schemes than any other trust in the country.

25 Jun 2012

New service known as ‘Senior Care’ provided by Intamac Systems

Intamac Systems Limited, the B2B Connected Home service provider announces the release of a new and improved ‘Senior Care’ service.

25 Jun 2012

Teleflex announces acquisition of Semprus BioSciences

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, announced it has acquired Semprus BioSciences, a biomedical company and spin out from Massachusetts Institute of Technology.

25 Jun 2012

MAP Pharmaceuticals completes End-of-Review meeting with FDA for LEVADEX NDA

MAP Pharmaceuticals, Inc. today announced that the Company completed an End-of-Review meeting with the United States Food and Drug Administration (FDA) for its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

25 Jun 2012

Watson enters new $1.8B senior secured term loan facility

Watson Pharmaceuticals, Inc. today announced that it has entered into a new senior secured term loan facility in an aggregate principal amount of $1.8 billion. Borrowings under the new term loan facility bear interest, at a rate equal to LIBOR plus an expected margin of 1.50%, which is subject to a ratings based margin grid. The new five year term loan is fully prepayable.

25 Jun 2012

iWorx launches IX-100BE Data Acquisition System with LabScribe2 Software

iWorx, a developer of advanced physiology research tools, has introduced the IX-100BE Data Acquisition System with LabScribe2 Software that provides high resolution/low noise recording of biopotential signals for OEM applications.

25 Jun 2012

Pfizer, Bristol-Myers Squibb receive FDA CRL for ELIQUIS NDA

Bristol-Myers Squibb Company and Pfizer announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for ELIQUIS (apixaban) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

25 Jun 2012

MEDNAX acquires Florida Atlantic Anesthesia

MEDNAX, Inc., today announced the acquisition of Florida Atlantic Anesthesia, Inc., a physician group practice that provides anesthesia services in Fort Lauderdale, Fla.

25 Jun 2012

Cell-free, biodegradable artery graft improves coronary artery bypass surgeries

With the University of Pittsburgh's development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery with no trace of synthetic graft materials left in the body.

25 Jun 2012

Researchers create endothelial cells with blood-brain barrier qualities

The blood-brain barrier -- the filter that governs what can and cannot come into contact with the mammalian brain -- is a marvel of nature. It effectively separates circulating blood from the fluid that bathes the brain, and it keeps out bacteria, viruses and other agents that could damage it.

25 Jun 2012

Inexpensive exome sequencing can quickly detect heterogeneous diseases

The first report of the diagnostic use of the technique of exome sequencing, where short sequences of DNA are analysed, shows that it can give good results at low cost, a researcher from The Netherlands will tell the annual conference of the European Society of Human Genetics.

25 Jun 2012

Studies look at how computer and mobile phone use affects mental health of young adults

Young adults who make particularly heavy use of mobile phones and computers run a greater risk of sleep disturbances, stress and symptoms of mental health. "Public health advice should therefore include information on the healthy use of this technology," says researcher Sara Thomée from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jun 2012

Older people with large waistlines have higher mortality rate

Older people with large waistlines have a higher mortality rate than those with a slim waistline. This was shown in a new study conducted by the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jun 2012

ETView’s VivaSight-DL product family receives pre-market clearance

ETView today announced that the company has received pre-market clearance for the VivaSight-DL product family following review of a Technical File submission by Medical Device Certification.

25 Jun 2012

New analysis finds increase in per-patient operating costs in PCMHs

The patient-centered medical home (PCMH) is a concept at the heart of many health care reform models that aim to both improve the quality of care and reduce wasteful spending. But a new analysis of federally qualified health centers finds that clinics with higher scores as medical homes also had higher per-patient operating costs.

25 Jun 2012